Lead author, Luis-Emilio Garca-Prez, MD, PhD, MBA, explained the key findings to Medical News Today : This was a post-hoc sub-group data analysis of the SURMOUNT-1, SURMOUNT-2, SURMOUNT-3 and SURMOUNT-4 phase 3 trials that showed tirzepatide injections (5 mg, 10 mg, 15 mg) significantly reduced body weight compared to placebo regardless of sex, with greater body weight reduction associated with tirzepatide in females compared to males. Luis-Emilio Garca-Prez, MD While the SM-1 and SM-2 trials involved randomization immediately after a screening period, SM-3 had a 12-week lead-in phase with intensive lifestyle changes, and SM-4 had a 36-week lead-in with open-label tripeptide treatment
Well break down whats included in the program, how it compares to other GLP-1 options, and whether its the right fit for your health goals
A representative for the pharmaceutical company said Novo Nordisk remains committed to ensuring patient safety, however, the safety data collected from large clinical-trial programs and post-marketing surveillance have not demonstrated a causal association between semaglutide or liraglutide and suicidal and self-harming thoughts. Amelia eventually addressed her concerns with her doctor and insisted on a lower dosage
Although independent relationships have been identified between GLP-1 therapy, gut microbiota composition, and skeletal muscle, direct evidence does not exist to show that microbial changes induced by GLP-1 provide protection against muscle loss during weight reduction caused by pharmacological means
How does Queen RX work